Bio/Pharma News

AbbVie to Acquire Stemcentrx

April 28, 2016

AbbVie will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T), a novel biomarker-specific therapy derived from cancer stem cells.

Bioanalyte Analyzer Shortens Measuring Time

April 25, 2016

Beckman Coulter Life Science’s new Vi-Cell Metaflex is designed to be operational for more than 22 hours a day.

US National Science and Technology Council Promotes Advanced Manufacturing

April 20, 2016

Equipment and Processing Report

The Subcommittee for Advanced Manufacturing of the National Science and Technology Council highlights biopharmaceutical manufacturing as an emerging priority.

Sanofi Invests €300 Million in Biologics Manufacturing Facility

April 19, 2016

Sanofi will invest in its Geel, Belgium facility in order to support its pipeline of monoclonal antibodies.

GSK Opens New Respiratory Manufacturing Facility

April 19, 2016

The facility located in Ware, UK, will be used to manufacture GSK’s Ellipta inhaler.

Shire Builds Biologics Manufacturing Campus in Ireland

April 18, 2016

Shire announces plans to build a flexible biopharmaceutical manufacturing facility in County Meath, Ireland.

Seattle Genetics Presents New Antibody-Drug Conjugate Data at AACR

April 18, 2016

Linker technology and drug combinations play an important role in the efficacy of ADCs.

Kite Pharma Pauses Selected Clinical Trials

April 18, 2016

The National Institute of Health will conduct an internal review of the National Cancer Institute’s cell manufacturing facilities, which will affect multiple Kite projects.

Juno Therapeutics and WuXi AppTec form JW Biotechnology

April 13, 2016

JW Biotechnology will focus on developing novel cell-based immunotherapies.

FDA Approves Tablet Production on Janssen Continuous Manufacturing Line

April 12, 2016

FDA approved an update in the manufacturing of Prezista (darunavir) using a continuous manufacturing line at Janssen Supply Chain’s facility in Puerto Rico.